FLT3 mutations have also been seen in myelodysplastic syndrome (MDS) in about 3–5% of newly diagnosed patients and in MDS patients without FLT3 mutations, they sometimes appear when these patients progress to AML [10]. This evidence concerns the gene FLT3 and acute myeloid leukemia.